ASBPW — Aspire Biopharma Holdings, Inc.

ASBPWAspire Biopharma Holdings, Inc.

NAS · US · Health Care · Biotechnology · aspirebiolabs.com

0.0168USDMkt Cap: —P/E: —Last update: 2026-05-22

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product th…

Industry Peers

Biotechnology

Alnylam Pharmaceuticals, Inc.

loading…

Indicators:|

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)34.55K USD

Gross Profit-116 USD

Net Income (TTM)-24.48M USD

Revenue/Share0.4260 USD

Last Price0.0168 USD

Fiscal Year End—

MR Quarter—

Employees—

CountryUS

SectorHealth Care

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B0.00

EPS (TTM)—

EPS (Forward)—

52W Range

0.015394% of range0.0169

52W High0.0169 USD

52W Low0.0153 USD

Profitability

Gross Margin-1.87%

Oper. Margin-5805.98%

EBITDA Margin0.00%

Profit Margin-394725.06%

ROE383.93%

ROA-1865.68%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-4.92M USD

CapEx (TTM)—

FCF Margin63450.70%

FCF Yield—

Net Debt-4.36M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity-0.81

Current Ratio2.26

Quick Ratio1.86

Book Value/Sh23.10 USD

Cash/Share4.522 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Splits

Last Split1:30

Split DateMay 11, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float1.20M

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)7.51K

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—